Godrej Properties (GODREJPROP.NS) traded up 1.92 % during a 24 hours period ending at 07:48 PM Central Europe on Tuesday 27th. One Godrej Properties stock can currently be bought for about INR 1,585.6 on popular exchanges. Current supply of Godrej Properties stocks is 301.2 mn. Godrej Properties has a current market capitalization of INR 450.8 bn and approximately INR 1.3 bn worth of Godrej Properties was traded on exchanges in the last 24 hours. Since last month end, Godrej Properties has traded -8.66 % down. Simple moving average of last 200 days is at INR 1,792.5. The highest price of past 52 weeks was recorded at INR 2,339 on 10/31/2025. 52 weeks low was at INR 1,434 on 04/02/2026.
Summary of the latest news for Godrej Properties
Godrej Properties Ltd. continues to focus on expanding its residential portfolio, with a new launch pipeline of projects worth roughly ₹32,000 cr slated for the second half of FY27. The company’s September quarter saw mixed pre‑sales, as several launches were deferred to the December quarter, but sustenance sales from existing inventory remained strong, rising significantly year‑on‑year. Cash generation remained robust, with collections and operating cash flow increasing markedly. Analysts highlight the company’s ability to convert its project pipeline into sales and cash collections as a key driver of future growth, while noting that execution in the coming quarters will be critical. Recent research reports maintain buy recommendations, citing the firm’s solid development track record, brand strength, and a focus on delivering a high‑quality customer experience, particularly in Pune where a new wellness‑centric study underscores shifting buyer preferences.
Here is how related stocks have performed in the past 24 hours:
Biocon (BIOCON.NS) traded down -2.06 % and now trades at INR 332.45. Current market capitalisation for Biocon is INR 529.8 bn. Biocon has a current price to earnings ratio of 99.18. Biocon Limited has announced a significant expansion of its biosimilar portfolio. The company secured a license with Janssen Sciences Ireland, granting immediate market entry for its proposed biosimilar to Stelara®—Yesintek™—in several additional countries, including Australia, Brazil, China, Hong Kong, Israel, Mexico, New Zealand, South Korea, and Kazakhstan. This follows prior agreements that opened U.S., European, UK, Canadian, and Japanese markets. The expansion aims to provide a more affordable treatment option for autoimmune conditions such as Crohn’s disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis. Concurrently, Biocon has scheduled an earnings conference call for analysts and investors on November 4, 2026, to discuss financial results for the quarter ended September 30. The company’s board meeting will also take place on the same day, with trading in its securities restricted from October 1 to November 6, 2026, in compliance with regulatory requirements.
Fortis Healthcare (FORTIS.NS) traded up 3.06 % and now trades at INR 736.5. Current market capitalisation for Fortis Healthcare is INR 538.2 bn. Current price/earnings ratio for Fortis Healthcare is 54.14.
Kalyan Jewellers India (KALYANKJIL.NS) traded down -3.47 % and now trades at INR 500. Kalyan Jewellers India has a market capitalisation of INR 528.8 bn. Current price/earnings ratio for Kalyan Jewellers India is 44.48. Kalyan Jewellers India Ltd. has announced a revised schedule for its forthcoming earnings conference call, which will now take place on 11 November 2026 at 08:30 AM IST. The meeting will cover the company’s financial and operational performance for the quarter ended 30 September 2026. Senior management, including the Executive Director, CEO, CFO, and other key officers, are slated to participate. The company’s corporate office remains in Thrissur, Kerala, and its regulatory filings have been updated accordingly. Analysts expect the company’s earnings per share and revenue for the quarter and the current fiscal year to rise compared with the previous year, with a projected increase in both profitability and top‑line growth. The call will provide stakeholders with detailed insights into the company’s recent results and future outlook.
Yes Bank (YESBANK.NS) traded up 0.38 % and now trades at INR 15.9. Current market capitalisation for Yes Bank is INR 496.3 bn. Current price/earnings ratio for Yes Bank is 12.41.
Mrf (MRF.NS) traded down -0.8 % and now trades at INR 118,030. Mrf has a market capitalisation of INR 500.1 bn. Mrf has a current price to earnings ratio of 21.18.